UK pharma industry signs landmark deal with government health service over drug prices
England’s National Health Service and the pharma industry on Monday morning announced a new five-year deal that will save the NHS £14 billion ($17.4 billion) …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.